Monetary Solutions’s Moderna MRNA Stock Holding History

Monetary Solutions’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-45	Closed	-$2.29K	–	402
2026 Q1	$2.29K	Hold	45	–	–	﹤0.01%	270
2025 Q4	$1.33K	Buy	+45	New	+$1.22K	﹤0.01%	285

Other funds holding MRNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

Monetary Solutions's MRNA Position: Q2 2026 in Review

Monetary Solutions sold out of Moderna (MRNA) in Q2 2026, closing a stake of 45 shares — an estimated $2.29K sold.

Monetary Solutions first reported a position in MRNA in Q4 2025 and held it in 2 quarters. The position peaked at $2.29K in Q1 2026. 585 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Monetary Solutions reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
Monetary Solutions sold 45 Moderna shares in Q2 2026, an estimated $2.29K.
Monetary Solutions first reported a position in Moderna in Q4 2025 and held it in 2 quarters.
Monetary Solutions's Moderna position peaked at $2.29K in Q1 2026.
585 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Monetary Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.